The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community

被引：11

作者：

Garibotto, Valentina ^{[1
,2
]}

Albert, Nathalie L. ^{[3
]}

Barthel, Henryk ^{[4
]}

van Berckel, Bart ^{[5
]}

Boellaard, Ronald ^{[5
]}

Brendel, Matthias ^{[3
,6
,7
]}

Cecchin, Diego ^{[8
]}

Ekmekcioglu, Ozgul ^{[9
]}

van de Giessen, Elsmarieke ^{[5
]}

Guedj, Eric ^{[10
]}

Lammerstma, Adriaan A. ^{[5
,11
]}

Semah, Franck ^{[12
]}

Traub-Weidinger, Tatjana ^{[13
]}

Van Weehaeghe, Donatienne ^{[14
]}

Morbelli, Silvia ^{[15
]}

机构：

[1] Univ Hosp Geneva, Diagnost Dept, Nucl Med & Mol Div, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland

[2] Univ Geneva, NIMTLab, Fac Med, Geneva, Switzerland

[3] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Nucl Med, Munich, Germany

[4] Univ Hosp Leipzig, Dept Nucl Med, Leipzig, Germany

[5] Univ Amsterdam, Dept Radiol & Nucl Med, Med Centers, Locat VUMC, Amsterdam, Netherlands

[6] DZNE German Ctr Neurodegenerat Dis, Munich, Germany

[7] Univ Munich, SyNergy, Munich, Germany

[8] Univ Hosp Padua, Dept Med DIMED, Nucl Med Unit, Padua, Italy

[9] Univ Hlth Sci, Sisli Hamidiye Etfal Educ & Res Hosp, Dept Nucl Med, Istanbul, Turkey

[10] Aix Marseille Univ, Cent Marseille, Timone Hosp, APHM,Nucl Med Dept,Inst Fresnel,CNRS,CERIMED, Marseille, France

[11] Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Dept Nucl Med & Mol Imaging, Groningen, Netherlands

[12] Univ Lille, CHU, Dept Nucl Med, Lille, France

[13] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Div Nucl Med, Vienna, Austria

[14] UZ Leuven, Nucl Med, Leuven, Belgium

[15] IRCCS Osped Policlin San Martino, Nucl Med Unit, Genoa, Italy

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / 10期

基金：

瑞士国家科学基金会;

关键词：

AMYLOID-PET; BIOMARKERS; DEMENTIA; TRIALS;

D O I：

10.1007/s00259-021-05485-y

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：3033 / 3036

页数：4

共 50 条

[11] Immunotherapy for Parkinson's Disease and Alzheimer's Disease: A Promising Disease-Modifying Therapy [J].

Mahboob, Anns ;

Ali, Hasan ;

Alnaimi, Aljazi ;

Yousef, Mahmoud ;

Rob, Mlaak ;

Al-Muhannadi, Nawaf Ahmad ;

Senevirathne, Degiri Kalana Lasanga ;

Chaari, Ali .

CELLS, 2024, 13 (18)

[12] Clinical Management in Alzheimer's Disease in the Era of Disease-Modifying Therapies [J].

Guo, Michael H. ;

Vaishnavi, Sanjeev N. .

CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2023, 25 (05) :121-133

[13] Clinical Management in Alzheimer’s Disease in the Era of Disease-Modifying Therapies [J].

Michael H. Guo ;

Sanjeev N. Vaishnavi .

Current Treatment Options in Neurology, 2023, 25 :121-133

[14] Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease [J].

Gustavsson, Anders ;

Pemberton-Ross, Peter ;

Montero, Melissa Gomez ;

Hashim, Mahmoud ;

Thompson, Robin .

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (06) :563-570

[15] Effect of mortality in cost-effectiveness modeling of disease-modifying treatment for Alzheimer's disease [J].

Aye, Sandar ;

Jonsson, Linus ;

Gustavsson, Anders ;

Tate, Ashley ;

Ptacek, Sara Garcia ;

Eriksdotter, Maria .

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2023, 15 (01)

[16] Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease [J].

Bateman, Randall J. ;

Cummings, Jeffrey ;

Schobel, Scott ;

Salloway, Stephen ;

Vellas, Bruno ;

Boada, Merce ;

Black, Sandra E. ;

Blennow, Kaj ;

Fontoura, Paulo ;

Klein, Gregory ;

Assuncao, Sheila Seleri ;

Smith, Janice ;

Doody, Rachelle S. .

ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)

[17] A Simulation Model to Evaluate the Potential Impact of Disease-Modifying Treatments on Burden of Illness in Alzheimer's Disease [J].

Tahami Monfared, Amir Abbas ;

Tafazzoli, Ali ;

Ye, Weicheng ;

Chavan, Ameya ;

Deger, Kristen A. ;

Zhang, Quanwu .

NEUROLOGY AND THERAPY, 2022, 11 (04) :1609-1623

[18] Expanded disease definitions in Alzheimer's disease and the new era of disease-modifying drugs [J].

Yim, Su Jin ;

Yasar, Sevil ;

Schoenborn, Nancy ;

Lang, Eddy .

BMJ EVIDENCE-BASED MEDICINE, 2025,

[19] The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer's disease [J].

Sarazin, Marie ;

Lagarde, Julien ;

El Haddad, Ines ;

de Souza, Leonardo Cruz ;

Bellier, Bertrand ;

Potier, Marie-Claude ;

Bottlaender, Michel ;

Dorothee, Guillaume .

NATURE AGING, 2024, 4 (06) :761-770

[20] Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease [J].

Assuncao, Sheila Seleri ;

Sperling, Reisa A. ;

Ritchie, Craig ;

Kerwin, Diana R. ;

Aisen, Paul S. ;

Lansdall, Claire ;

Atri, Alireza ;

Cummings, Jeffrey .

ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)

← 1 2 3 4 5 →